tirzepatide 1 week results TrimRX My 40-Pound Weight Loss Journey

If symptoms get worse or you notice severe issues like bad stomach pain or an allergic reaction, reach out to your doctor right away

Efficacy and safety of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: A double-blind, randomized, phase 3 trial

This treatment may be self-administered in the comfort of the patients own home or at either our Somerville or Florham Park office

Results May Vary: Individual results vary based on many factors including age, baseline health, lifestyle, consistency of use, genetics, and other variables

Regular monitoring of inflammatory markers, disease activity scores, and functional status remains essential regardless of concurrent GLP-1 use

Lobstein et al., 2023)